ZBIO
Zenas BioPharma, Inc.
27.00$
-2.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.8% | 87.7% | 96.2% | 91.5% | |
| 90.1% | 83.4% | 86.4% | 28.8% | |
| 90.1% | 83.4% | 94.8% | 89.5% | |
| 357.8% | 431.1% | 15.5% | 36.9% | |
| 34.8% | 34.1% | 15.5% | 16.3% | |
| 1.0% | 0.8% | 0.2% | 0.3% | |
| 7.8% | 7.9% | 4.6% | 1.9% | |
| – | 29.8% | – | – | |
| -257.8% | -331.1% | 84.5% | 63.1% | |
| -259.2% | -337.9% | -104.7% | -199.4% | |
| 51.4% | 56.2% | 11.3% | 11.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.